What is Genenta Science SpA ADR (GNTA) stock price today?

Genenta Science SpA ADR (GNTA) currently trades at $0.71 per share. The stock has a market capitalization of $16.71M and a P/E ratio of —x.

Is GNTA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Genenta Science SpA ADR has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -2.48.

Is Genenta Science SpA ADR financially healthy?

Genenta Science SpA ADR's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -2.48 places it in the distress.

GNTA

Genenta Science SpA ADR

NASDAQ: GNTA · HEALTHCARE · BIOTECHNOLOGY

$0.71

-1.99% today

Updated 2026-04-29

Market cap

$16.71M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.39

Dividend yield

—

52W range

$1 – $6

Volume

0.1M

Market cap

$16.71M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.39

Dividend yield

—

52W range

$1 – $6

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-2.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$6.99

+891.49%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -2.48 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.69M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-8.28M	$-11.44M	$-9.31M	$-6.27M	$-2.68M
EPS	—	—	—	—	$-0.39
Free cash flow	$-7.45M	$-11.22M	$-6.24M	$-6.88M	$-1.69M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GNTA	$16.71M	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Genenta Science SpA ADR trades at $0.71. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.48, it sits in the distress.

Frequently asked questions

What is Genenta Science SpA ADR's stock price?

Genenta Science SpA ADR (GNTA) trades at $0.71.

Is Genenta Science SpA ADR overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Genenta Science SpA ADR (GNTA)?

The analyst target price is $6.99, representing +891.5% upside from the current price of $0.71.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-2.48 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.genenta.com

Quick metrics

P/S ratio—

ROE-38.00%

Beta0.71

50D MA$0.79

200D MA$2.14

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GNTA vs LLY →GNTA vs JNJ →GNTA vs ABBV →Stock screener →